of neonatal germinal matrix haemorrhage using stereotactic injection of autologous blood into the mouse neonatal germinal matrix. Pathological analysis at 4 days postinjury showed high rates of intraventricular extension and ventricular dilatation but low rates of parenchymal disruption outside the germinal zone, recapitulating key features of human "Papile grade III" IVH. At 4 days postinjury we observed proliferation in the wall of the lateral ventricle with significantly increased numbers of transient amplifying cells within the SVZ and the corpus callosum. Analysis at 21 days postinjury revealed that cortical development was also affected, with increased neuronal and concomitant reduced oligodendroglial differentiation. At the molecular level, we showed downregulation of the expression of the transmembrane receptor Notch2 in CD133 +ve cells of the SVZ, raising the possibility that the burst of precocious proliferation seen in our experimental mouse model and the skewed differentiation could be mediated by downregulation of the Notch pathway within the proximal/ventricular domain. These findings raise the possibility that Notch regulation plays a critical role in mediating the response of the neonatal SVZ to ischaemic and haemorrhagic insults. 
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Introduction
Delayed primigravida (first pregnancy) and the use of in vitro fertilisation have contributed to an increase in the incidence of premature birth in all developed countries [1, 2] and, despite advances in perinatal care, haemorrhage within the germinal matrix (GM) remains a commonly recognised complication seen in up to 45% of extremely premature babies weighing 500-750 g [3] . The cause of brain injury associated with premature birth is complex and multifactorial, with ischaemia [4] and inflammation [5] playing key roles. In addition, outcome has been shown to correlate with the severity of haemorrhage, with extension into the ventricle and loss of brain parenchyma secondary to porencephalic cyst formation being associated with significant neurodevelopmental disabilities [6] [7] [8] . Preventing premature birth and reducing the incidence of haemorrhage remain key research goals. However, the need for new modalities of treatment to limit neurodisability in this vulnerable patient group is clearly evident.
In order for normal brain development to take place, the behaviour of neural stem/progenitor cells (NSPC) is tightly regulated in both a temporal and a spatial fashion. This occurs through the balance of cell-intrinsic mechanisms and microenvironmental factors [9, 10] . The microenvironment within the GM in which the neural stem cells (NSC) reside can be conceptualised as consisting of 3 domains [10] : the proximal/ventricular domain which responds to signalling within the CSF [11] and from interaction with the ependymal cells [12] , the intermediate zone in which the NSC responds to cues arising from the intermediate progenitor cells [13, 14] and neurotransmitters released within the subventricular zone (SVZ) [15] , and the distal/basal domain which is under the influence of cues from the circulation and endothelial cells [16] . Plausible mechanisms can be envisaged through which any and all of these microenvironmental domains could be affected due to germinal matrix haemorrhage (GMH).
Whilst GABAergic interneurons are known to arise from the SVZ in the final trimester [17] [18] [19] , lineage-tracing experiments have highlighted the critical role that the GM plays in the production of astrocytic and oligodendrocytic precursors [20] , with the majority of oligodendrocytes developing during late embryogenesis and early postnatal life [21] . This surge in progenitor formation coincides with the peak incidence of GMH (23-28 weeks) and, given the critical role that the oligodendrocyte lineage is likely to play in the aetiology of encephalopathy of prematurity [22] , we hypothesised that GMH might be responsible for a primary stem cell disorder in an otherwise developmentally normal brain (i.e., no underlying genetic/pathological abnormality), making it an appealing target for therapeutic intervention.
GMH is recognised to have both destructive and developmental impacts on the developing brain of the premature neonate [23] . To date, published models of intraventricular haemorrhage (IVH) have focused on modelling severe haemorrhage, with large parenchymal defects seen [24] [25] [26] [27] . This approach is likely to mask the more subtle developmental impact of IVH on the NSPC within the SVZ; as such, we endeavoured to produce a model with minimal cortical disruption to uncover this subtle mechanism.
Combining stereotactic injection of autologous blood at P0 [28] with a thymidine labelling strategy at P1 [29] , we showed that GMH caused activation of proliferation in the wall of the lateral ventricle, which eventually resulted in an altered cellular composition of the cortex with an increased number of neuronal elements and a concomitant depletion of oligodendrocytes. Expression analysis of the CD133/prominin-positive cell fraction (a transmembrane glycoprotein expressed by NSC and ependymal cells within the lateral ventricle during early postnatal development) [30] demonstrated downregulation in the expression of Notch2, a well-known regulator of NSPC function in the proximal/ventricular domain [9, 31] , in these cells following GMH.
Materials and Methods

Animals
All procedures had Home Office approval (Animals Scientific Procedures Act 1986, PPL 70/7275). C57BL/6 mice were used throughout. Cages were checked daily and intracranial autologous blood injections were undertaken on the afternoon of the first day of life.
Stereotactic Intracranial Injection of Autologous Blood
To facilitate accurate and reproducible restraint of the P0 pup, modifications were made to a Narishige stereotactic frame based on the work of Merkle et al. [28] (Fig. 1a, b) . P0 pups were anaesthetised on ice for 3 min and 30 s prior to being fixed into the frame. Autologous blood collected from the tail tip (Microvette TM CB300 VWR) was injected via a customized 1-cm 30-gauge needle 1 mm posterior and 1.5 mm superior to the posterior border of the left eye with a forward angulation of 24 degrees and a depth of 2 mm (online suppl. Fig. S1 ; for all online suppl. material, see www. karger.com/doi/10.1159/000455839). In the sham group, all experimental conditions were equivalent with the exception that the mice underwent needle injection only without blood injection. 
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EdU Administration Intraperitoneal injections of EdU (12.5 mg/kg; Life Technologies TM ) were given on day 1 of life, according to published protocols [29] .
Immunohistochemistry and Histology
Mice were transcardially perfused under terminal anaesthesia with 0.9% saline followed by 4% paraformaldehyde. Brains were dissected and postfixed for 2 h in 4% paraformaldehyde at 4 ° C. Tissue was cryoprotected with 30% sucrose overnight, mounted in O.C.T. (VWR TM ) medium, and sectioned at 10 μm on a cryostat (Leica TM ).
For EdU staining, samples were blocked with 3% BSA (Sigma TM )/phosphate-buffered saline/0.1% Triton X100 and incubated for 30 
Volumetric Analysis Using a Cavalieri Probe
To quantify ventricular volume, we adopted a stereological approach using the Cavalieri estimator probe within Stereoinvestigator (MBF Bioscience TM ). On the coronal plane, volumetric analysis was undertaken between the induseum griseum (anterior zero section) and the appearance of the hippocampus in continuity across the midline (posterior zero section) (online suppl. Fig. S2 ), with every tenth section analysed. On the sagittal plane, volume acquisition was undertaken from the sagittal zero section (online suppl. Fig. S3 ) (defined as the first appearance of the striatum within the rostral migratory stream) and 2 further sections at 150 and 300 μm medial to the sagittal zero.
Image Acquisition and Analysis
All images were acquired using a Zeiss TM 710LSM confocal microscope and a ×40 oil immersion objective lens and analysed using either tile scanning and ImageJ TM or the Optical Fractionator probe of Stereoinvestigator (MBF Bioscience TM ). For analysis of the SVZ, 3 coronal specimens per sample were analysed [zero slide (Z), Z + 150 μm, and Z + 300 μm], with all cells counted within the lateral and superior wall of the ventricle within the immediate hypercellular periventricular region. Any staining which was not clearly nuclear was not counted. Within the corpus callosum, a 300-pixel-wide counting frame was taken through the corpus callosum positioned anterior to a perpendicular line taken from the anterior border of the hippocampus through the cortex (Fig. 3) . Three samples per specimen were analysed (sagittal -Z, Z -150 μm, and Z -300 μm). Within the neocortex, quantification was undertaken on 3 sagittally orientated samples with all of the neocortex included anterior to a perpendicular line taken from the anterior border of the hippocampus (Fig. 5a ).
Behavioural Analysis
Daily behavioural analysis between P2 and P21 was undertaken. Reflex development was assessed using grip strength, negative geotaxis, cliff aversion, and surface righting (online suppl. Fig. S4 ). Neuromotor development was assessed for 3 min in a Perspex open-field chamber (50 × 50 cm); the number of head, shoulder pelvis lifts, head pointing and sniffing, sitting, rearing, and falls were recorded using key presses, whilst the distance travelled and the speed were recorded using proprietary Anymaze software. 
Extraction Amplification and
ISH Analysis
The Hes 5 probe was kindly donated by the Kriegstein lab (previously published in the study of Muzio et al. 2005 [32] ) and the in situ hybridization was carried out according to standard protocols [33] .
Statistical Analysis
Statistical analysis was undertaken using GraphPad Prism, and a t test and one-way ANOVA in conjunction with Tukey's test for multiple comparisons were applied for comparisons between 2 datasets or multiple datasets, respectively. A linear growth model was used to compare behavioural parameters.
Results
Establishment of a Mouse Model of GMH by Stereotactic Injection of Autologous Blood into the Neonatal Mouse SVZ
In our experience, use of a published freehand injection of 15 uL of autologous blood with a 26-gauge needle into the newborn mouse pup [26] caused significant morbidity and mortality and was associated with high levels of subdural extension of blood, significant damage to the surrounding cortex, and marked variability in the injection site.
Stereotactic injection in newborn mouse pups using conventional equipment is limited due to the lack of re-straints, as such modifications were made to a Narishige stereotactic frame based on the work of Merkle et al. [28] ( Fig. 1 a) . The custom-made clay mould (inset in Fig. 1 a) , in combination with nose and body taping ( Fig. 1 b) , facilitated accurate and reproducible restraint.
Tissue dye injection into euthanized newborn (P0) mouse pups followed by histopathological examination of coronal brain samples was used to define the injection coordinates and trajectory (online suppl. Fig. S1 ). The site of the blood bolus, its vicinity to the anterior SVZ, the degree of damage to the surrounding parenchyma, and the rate of intraventricular spread in comparison to subdural extension were analysed. The optimal injection coordinates were found to be: 1 mm posterior and 1.5 mm superior to the posterior border of the eye with a forward angulation of 24 degrees, at a depth of 2 mm ( Fig. 1 c; online suppl. Fig. S1 ). The longer trajectory used in the forward angulated approach was found to reduce bleed back along the needle tract, with an increased volume of the SVZ seen to be affected by the blood bolus; it also facilitated injection of the anterior SVZ without the risk of damaging the eye. The needle used for injection was a custom-made Hamilton TM 30-gauge 1-cm needle; lowergauge needles were associated with increased mortality and caused unacceptably high levels of tissue damage, and higher-gauge needles were liable to bending or slippage, reducing the reproducibility of the injection site. We injected 5 uL of whole blood, an amount that is easily and atraumatically extracted from the tail tip and does not significantly impact the circulating volume; it also limits the adverse impact of bolus size on tissue distortion and intracranial pressure.
Histological analysis was carried out on coronally sectioned brains on day 1 (P1) following stereotactic blood injection on the day of birth (P0), and it showed the haematoma to be consistently located within the SVZ with variable intraventricular spreading ( Fig. 1 d) . Minimal damage to the surrounding cortex was noted and the overall mortality was low on day 4, with no late mortality seen. On day 4 (P4) an incipient haematoma cavity was noted within the SVZ with frequent cells of macrophagic lineage scavenging blood products within the SVZ, in keeping with siderophages (macrophages laden with iron) ( Fig. 1 e) .
We showed that modification of the Narishige stereotactic frame as described above facilitates accurate and reproducible lesioning within the SVZ of the newborn mouse pup and could represent a useful tool to study the effect of GMH on the SVZ NSPC and on early cortical development.
GMH Causes Ventriculomegaly on P4, which Persists up to P21
Histological examination of Nissl-stained samples demonstrated significant ventriculomegaly in the bloodinjected samples in comparison with the control samples. To quantify ventricular volume, we adopted a stereological approach using the Cavalieri estimator probe within Stereoinvestigator (MBF Bioscience TM ). Due to potential distortion of the parenchyma on the rostrocaudal plane secondary to GMH, volumetric analysis was undertaken between fixed anterior and posterior points to ensure reproducibility. Using the indusium griseum/ first appearance of the corpus callosum in continuity as the most anterior slide and the appearance of the hippocampus in continuity across the midline as the posterior slide (online suppl. Fig. S2A-D) , an equal number of sections was generated for analysis [control ( n = 8), 73.63 ± 3.8 sections; sham ( n = 5), 73.4 ± 2.4 sections; and GMH ( n = 7), 77 ± 4.8 sections; p = 0.78, ANOVA] (online suppl. Fig. S2F ).
Quantitative assessment of volume on the coronal plane between the induseum griseum and the first appearance of the hippocampus in continuity revealed that blood injection caused significant ventriculomegaly at P4 [control ( n = 7), 0.054 ± 0.007 mm 3 ; sham ( n = 4), 0.053 ± 0.003 mm 3 ; and GMH ( n = 5), 0.078 ± 0.005 mm 3 ; p = 0.02, ANOVA] ( Fig. 1 f) and this was shown to persist up to P21 [control ( n = 5), 0.003 ± 0.0004 mm 3 , and GMH ( n = 4), 0.015 ± 0.005 mm 3 ; p = 0.03, t test) ( Fig. 1 g, h) . Ventriculomegaly was not seen in the sham mice. Volume analysis within the corpus callosum, the SVZ, and the cortex at P4 and P21 demonstrated no significant difference between the control and GMH pups, indicating that the increase in ventricular volume was not due to parenchymal loss.
We have shown that the experimental model of moderate GMH we developed causes ventriculomegaly at P4 which persists up to P21, faithfully recapitulating a key feature of the human condition.
GMH Causes Increased Proliferation in the Wall of the Lateral Ventricle
To assess the impact of GMH on the NSPC within the SVZ, we adopted a thymidine labelling strategy previously published by Inta et al. [29] . The number of EdU +ve cells within the lateral wall of the lateral ventricle was quantified after 3 days and a significant increase was found in the GMH samples as compared to controls [control ( n = 4), 57.5 ± 8.605; sham ( n = 5), 80.23 ± 5.008; and GMH ( n = 4), 165 ± 24.09; p = 0.0008, ANOVA] ( Fig. 2 a, b) . Stereotactic injection of autologous blood recapitulates moderate-grade germinal matrix haemorrhage (GMH). a The Narishige stereotactic frame was modified with a clay mould ( inset ) secured to a custom-made board shaped to fit the space in which the proprietary metal plate would ordinarily sit. The board was secured using the housing screws shown and in combination with the taping shown in b this method facilitates reproducible immobilisation of the P0 mouse pup. c Schematic showing the point of bolus injection within the anterior margin of the subventricular zone (left); macroscopic picture showing the result of tissue dye injection into the subventricular zone -a small entry wound and needle tract can be seen leading to the injection bolus within the anterior subventricular zone, and bilateral intraventricular spread can also be clearly seen (middle); matching macroscopic picture showing the result of blood injection into the subventricular zone -a tiny entry wound with a very similar distribution of intraventricular blood can be seen, the relative lack of surrounding tissue damage and the absence of any subdural blood is also noted (right). d Coronal section of a P1 mouse brain stained with haematoxylin and eosin at a ×5 magnification (left) and a ×10 magnification (right), following stereotactic blood injection on the day of birth (P0), demonstrating haematoma within the subventricular zone (white arrow) in association with intraventricular blood (red arrow). Minimal damage to the surrounding cortex is noted. e Coronal section of a P4 mouse brain stained with haematoxylin and eosin at a ×10 magnification (left) and a ×40 magnification (right), demonstrating a haematoma cavity within the subventricular zone (black arrow) associated with the presence of siderophages (green arrows). f GMH causes ventriculomegaly at P4 (control, n = 7; sham, n = 4; and GMH, n = 5; p < 0.05, ANOVA). g Similarly at P21 we see persistence of ventriculomegaly (control, n = 5, and GMH, n = 4; p < 0.05, t test). h The persistence of hydrocephalus following GMH can be seen at P21 in the small stature and marked doming of the cranium [ inset (top): comparison of a control pup (a) with a GMH pup (b) demonstrates small stature on P21 in the GMH pups; inset (bottom): coronal view of the brain with dilated lateral ventricles] (* p < 0.05).
Importantly, sham injection did not elicit a similar effect, therefore excluding the possibility that the observed phenotype was due to the injection alone. EdU staining was found to be tightly confined to DAPI +ve nuclei, and no picnotic/apoptotic cells were seen in the wall of the lateral ventricle. The pattern of EdU staining was also seen to change from a solid high-intensity signal in the control setting to a more fragmented and less intense signal in the GMH sample, implicating a dilution of the EdU signal secondary to increased proliferation ( Fig. 2 a) .
To determine if the increase in EdU +ve cells could be accounted for by an increase in the number of transient amplifying cells, we costained for the nuclear marker MASH1 (ASCL1) which has been shown to be expressed at high levels in transient amplifying cells [9] . This demonstrated a significant increase in the number of 
MASH1
+ve cells within the wall of the lateral ventricle in the GMH samples [control ( n = 4), 67 ± 10.24, and GMH ( n = 4), 178 ± 27.84; p = 0.0096, t test] ( Fig. 2 c-e) . Staining for GFAP (gliogenic lineage) ( Fig. 2 a, d, Fig. S5 ).
In summary, we have shown that GMH causes an increase in the number of EdU +ve cells within the wall of the lateral ventricle, with a significant increase in the number of transient amplifying cells and glial cells.
GMH Causes an Increase in the Number of NG2 +ve Progenitors within the Corpus Callosum
While carrying out the analysis within the lateral wall of the lateral ventricle as described above, it became apparent that increased numbers of EdU +ve cells were also seen within the callosal/dorsal border of the ventricle, a finding which was also seen in MASH1 staining ( Fig. 2 c) . This area was recognised by Suzuki and Goldman [34] as a key postnatal gliogenic migratory pathway out of the SVZ and into the cortex ( Fig. 3 a) ; thus, to quantify this increase, analysis was undertaken within the corpus callosum on an independent series of sagittally sectioned brains ( Fig. 3 b, c) .
The first most striking finding was that the blood-injected samples exhibited a different morphology within the corpus callosum. The normal perpendicular arrangement of cells was replaced by a markedly hypercellular and disordered pattern ( Fig. 3 d) . Quantification of the number of EdU +ve cells again demonstrated a significant increase following IC blood injection, which was not found in the sham control [control ( n = 6), 32.73 ± 1.386; sham ( n = 5), 35.03 ± 1.662; and GMH ( n = 6), 49.09 ± 4.83; p = 0.0049, ANOVA] ( Fig. 3 e) . Colocalisation revealed a significant increase in NG2
+ve EdU +ve cells [control ( n = 6), 11.67 ± 2.362, and GMH ( n = 6), 20.17 ± 1.558; p = 0.013, t test), with a trend for increase also seen in the GFAP +ve / EdU +ve population, whilst no increase was seen in the number of cells colocalising EdU and Dcx ( Fig. 4 ) .
The corpus callosum is thought to represent a major conduit of glial progenitors migrating from the SVZ to the cortex [34] . Here we showed that GMH not only impacts on the SVZ but also leads to an increase in the number of NG2 +ve lineage-committed progenitors in the corpus callosum.
Reduced Expression of Olig2 at P21 after GMH
Given that we have shown that GMH causes phenotypic changes within the SVZ and the corpus callosum at an acute/immediate stage (P4), we resolved to determine how this might impact early cortical development. To achieve this, we analysed the neocortex from P21 mice as this was felt to be representative of juvenile brain development ( Fig. 5 a) .
We found that GMH causes a significant reduction in the percentage of EdU +ve cells [control ( n = 3), 13.66 ± 0.86, and GMH ( n = 3), 9.88 ± 0.45; p = 0.017, t test] ( Fig. 5 b) throughout the cortex and it was not limited to any specific layer. Costaining with the panneuronal marker NeuN revealed that in the control setting less than 1% of the DAPI cells counted were found to be labelled for both EdU and NeuN and this was not found to be significantly affected by GMH ( Fig. 5 c) .
Further costaining with the oligodendrocyte marker Olig2 revealed that while in the control setting around 9% of the cells were labelled with EdU and Olig2 this was seen to drop significantly to around 6% following GMH [con- Fig. 3 . Germinal matrix haemorrhage (GMH) leads to an increase in the number of EdU +ve transient amplifying cells within the corpus callosum. a Sagittal schematic representation of the P4 mouse brain demonstrating the postnatal migratory patterns out of the subventricular zone (SVZ) (adapted from Suzuki and Goldman [34] ). Neuronal migration into the olfactory bulb is shown in green whilst glial migratory pathways are shown in yellow and orange. b Sagittal single-channel DAPI image from a P4 mouse pup demonstrating the positioning of the 300-pixel-wide counting frame (rectangle) orientated anterior to a line drawn perpendicular to the anterior border of the hippocampus (double-headed arrow). c Example of the counting frame used for quantification in the sagittal analysis. Left: single-channel DAPI image demonstrating 4 phenotypically different regions: the SVZ, the corpus callosum (CC), the subcortical white matter (SCWM), and the cortex (CTX). Quantification was undertaken within the CC. Middle: myelin basic protein (green) staining used to demonstrate the anatomical boundaries between the SCWM and the CC facilitating quantification within the CC. Right: single-channel myelin basic protein highlighting the different orientation of myelin staining seen in the SCWM, CC, and CTX . d Oil tile scans (×40) (blue, DAPI, and green, EdU) following GMH shows that the cellular architecture within the CC is abnormal, with markedly increased cellularity and loss of the perpendicular arrangement of nuclei (as seen in the control samples). Similarly, we see a significant increase in the number of EdU +ve cells within the SVZ and the CC whilst the SCWM and the CTX remain relatively unaffected. e Quantification of the number of EdU +ve cells within the counting frame of the CC reveals that GMH causes a significant increase in the number of EdU +ve cells (control, n = 6; sham, n = 5; and GMH, n = 6; p < 0.01, ANOVA). Scale bars, 100 μm (* p < 0.05; ** p < 0.01). ( Fig. 5 d) . Similarly, the percentage of cells expressing Olig2 was seen to significantly decrease following GMH [control ( n = 3), 12.69 ± 0.53, and GMH ( n = 3), 9.63 ± 0.61; p = 0.019, t test] ( Fig. 5 e) .
Taken together, these data suggest that GMH has a negative impact on postnatal oligodendrogenesis while not significantly affecting postnatal neurogenesis. Whether this is due to direct toxicity or to an impact on differentiation or migration of oligodendrocyte precursors remains to be definitively clarified.
Moderate GMH Causes Transient Early Impacts on Neonatal Development
Following IC blood injection at P0, we observed an increased number of falls [control ( n = 15), 4.5; sham ( n = 12), 9.33; and GMH ( n = 21), 22.23; ANOVA] and significantly more fails in grip strength testing [control ( n = 15), 1.875; sham ( n = 12), 1.83; and GMH ( n = 21), 2.47; ANO-VA] from P3 to P6; however, this difference did not persist and, contrary to published models of GMH (Aquilina et al. [24] , Xue et al. [26] , Lekic et al. [25] ), we found no persistent deficits/alterations in neuromotor development up to Fig. S4 ). This finding differentiates our model as being more representative of low-grade GMH, i.e., Papile grades II and III in contrast with the grade IV haemorrhage modelled by previously published studies [24] [25] [26] . This finding further reinforces the need for this model of low-grade GMH and implies that the global impact of grade IV haemorrhage may mask the more subtle impact that GMH/IVH has on the NSPC within the SVZ.
GMH Causes Notch Downregulation in CD133 +ve
Cells in the SVZ Next, we set out to assess the impact of GMH on molecular regulation within the proximal/ventricular domain. To this end, MACS sorting of prominin/CD133-labelled cells from a single hemisphere of P4 blood-injected versus control pups was carried out. Prominin is a transmembrane glycoprotein expressed by ependymal cells and on the primary cilia of NSPC [35] within the SVZ its expression decreases throughout the course of gestation but it is highly conserved within the ventricular/ proximal domain at P4 [36] .
Expression analysis of a selection of genes known to play a role in SVZ NSPC regulation was carried out on RNA extracted from the injured hemisphere of 3 animals and uninjured controls. Eight genes were found to be significantly deregulated, with only Hsp90ab1 being upregulated and all others, i.e., Notch2, Ep300, Kat2a, Sox2, Cxcl12, Tubb3, and Ccne1 downregulated ( Fig. 6 a) .
Given the integral role that the Notch pathway has in modulating stem cell proliferation and differentiation, we were intrigued to find that Notch 2 expression was downregulated >25-fold following GMH. To validate these findings, in situ hybridisation for the Notch pathway effector Hes5 was used (control, n = 3, and GMH, n = 3). In the uninjured P4 SVZ, Hes5 was expressed in both the ependymal lining and a few scattered GFAP +ve cells, as demonstrated by double staining for GFAP/Hes5 ( Fig. 5 b) . A striking reduction of Hes5 staining was ob- Germinal matrix haemorrhage (GMH) at P0 impacts early cortical development (quantified on P21). a Quantification was undertaken in the neocortex anterior to a line drawn perpendicular to anterior border of the hippocampus (area shaded in red). b GMH at P0 significantly reduces the percentage of cells which express EdU within the cortex at P21 (control, n = 3, and GMH, n = 3; p < 0.05, t test). c No significant change is seen in the percentage of cells which colocalise EdU and NeuN (control, n = 3, and GMH, n = 3; p = 0.1, t test). d In contrast, analysis of colocalisation with markers of oligodendrocytic lineage reveals that GMH significantly reduces the proportion of cells which colocalise EdU and Olig2 (control, n = 3, and GMH, n = 3; p < 0.01, t test). e Similarly, following GMH at P0 we see a significant reduction in the percentage of cells which express the oligodendrocyte marker Olig2 (control, n = 3, and GMH, n = 3; p < 0.05, t test) (* p < 0.05; ** p < 0.01). served in the SVZ of P4 mice following GMH in all of the samples tested, and this was particularly marked in the anterior SVZ ( Fig. 5 c) .
The observed downregulation of the Notch pathway in CD133 +ve cells in the SVZ after GMH raises the possibility that Notch signalling could be functionally mediating the proliferative burst of transient amplifying cells with subsequent aberrant differentiation observed in the mature cortex.
Discussion
Despite advances in perinatal care, encephalopathy of prematurity is still a common cause of disability in children and GMH is the most prevalent intracranial lesion seen in premature babies [37] . Due to the multifactorial nature of encephalopathy of prematurity [23] , isolating the impact of GMH and deciphering its effect on the NSPC and cortical development remains elusive. Germinal matrix haemorrhage (GMH) causes downregulation of Notch2 in CD133-positive cells within the wall of the lateral ventricle. a RNA analysis from the CD133 +ve cell fraction isolated from the wall of the lateral ventricle reveals that GMH causes significant downregulation of Ccne1, Cxcl12, Ep300, Kat2a, Notch2, Sox2, and Tubb3 and significant upregulation of Hsp90ab1 (control, n = 3, and GMH, n = 3; p values shown were calculated using a t test). b By overlaying the Hes5 ISH with the GFAP/EdU IHC, we confirm the expression of Notch within the wall of the lateral ventricle predominantly in GFAP -ve cells with occasional expression in GFAP +ve cells. c Photomicrographs showing in situ hybridisation performed using a Hes5 probe [32] on coronal sectioned P4 mouse brain. Specific localisation of the Hes5 probe to the wall of the lateral ventricle in the control setting is clearly seen (top left and right) with a significant reduction in Hes5 expression following GMH (bottom left and right).
The severity of haemorrhage correlates with outcomes [38] and ranges from minor bleeds within the substance of the GM to significant life-threatening haemorrhages, which extend into the ventricle causing florid hydrocephalus and associated venous infarction [39] . There is widespread agreement that the outcome following high-grade haemorrhage is poor [40] , and this is likely due in part to the destructive impact on the parenchyma [23] . However, the outcome following moderate/low-grade haemorrhage is more variable, with contradictory reports in the literature [41] [42] [43] . More advanced neuroimaging techniques have revealed that, even if development appears outwardly normal, functional MRI imaging following premature birth shows markedly abnormal connectivity and synchronisation [44, 45] and volumetric analysis indicates a reduced brain size and cortical gyration [46] [47] [48] [49] . Postnatally developed neuronal cells [4] with reduced dendritic arborisation [45] are also being increasingly recognised as important consequences of premature birth.
Given the clinical significance of GMH, numerous models in different animal species have been trialled [50] ; however, to date all models have focused on the severe end of the spectrum with extensive cortical injury where diffuse haemorrhage and marked disturbances in behaviour are seen [25, 51, 52] . It is well recognised that NSPC within the SVZ are exquisitely sensitive to microenvironmental cues [9, 10] and further that haemorrhage within the ventricle alters the expression of NSC modulators, such as TGFβ [53] . Thus, in order to understand how GMH impacts NSPC and cortical development in the intermediate group, in whom outcomes appear to be most variable and who may have the most to gain from intervention, a more subtle injury model is needed. Currently available physiological techniques [52] cannot be used to model low-grade GMH as it causes widespread haemorrhage within the brain parenchyma [50] and may also be confounded by the use of glycerol, which has been shown to impact cortical development independently [54] . Similarly, the interpretation of results following the injection of collagenase into the SVZ [25] , whilst reducing bolus size, is significantly limited due to the potentially confounding affect of collagenase on the NSPC.
Modelling intracerebral haemorrhage through targeted mutations within components of the blood-brain barrier has been instrumental in determining the aetiology of GMH; for example, the roles of integrins [55] , collagen [56] , and pericytes [57] have all been shown. Furthermore, using a tetracycline-inducible system to initiate VEGF expression within the GM of the developing embryo, Yang et al. [58] showed high rates of IVH. The transgenic models developed to date invariably cause intrauterine bleeding and are associated with a high perinatal mortality. Thus, no widely accepted transgenic model of neonatal GMH has yet been developed to determine how postnatal haemorrhage impacts cortical development.
We chose to use injection of autologous blood to circumvent the potentially misleading influence of using nonphysiological substances. Similarly, reducing the volume of injection to 5 uL and employing a stereotactic injection technique limits the kinetic impact of the blood bolus and focuses the lesion within the SVZ whilst limiting the collateral damage to the surrounding parenchyma. The fact that stereotactic blood injection causes minimal primary damage to the cortex with low rates of porencephalic cyst formation, whilst accurately modelling ventriculomegaly and microglial activation, reinforces the premise that the effect of GMH, in this model, is subtle and offers a unique opportunity to understand how moderate degrees of haemorrhage impact on the NSPC and cortical development.
Our primary finding of an increased number of EdU +ve cells in the wall of the lateral ventricle at P4 following GMH at P0 was initially unexpected given that a previous blood injection model had shown a reduction in proliferation following GMH [26] . This likely reflects the different degrees of haemorrhage modelled by the two approaches. The finding of activation of proliferation following GMH is in keeping with ischaemic models of premature brain injury [59] ; whilst differences may exist in the temporal course (delayed response seen following ischaemia and a more immediate response seen following haemorrhage), this finding suggests activation of a common pathway following brain injury in the premature neonate. Costaining within the SVZ at P4 revealed that the increase in EdU +ve cells seen following GMH was in part accounted for by an increase in the number of MASH1 +ve and GFAP +ve progenitor cells. In addition to this, analysis of the postnatal gliogenic migratory pathway out of the SVZ [34] (i.e., within the corpus callosum) revealed a significant increase in the number of glial progenitors (EdU +ve /NG2 +ve ) following GMH/IVH. This combination of findings implicates that moderate-grade GMH associated with intraventricular extension causes activation of proliferation within the SVZ, with a consequent increase in the number of glial progenitors within the postnatal migratory pathways.
Interestingly, by analysing the neocortex at P21 we found that this initial burst of proliferation of glial pro- genitors did not increase the proportion of glial cells within the cortex. Indeed, the opposite was seen, with reduced numbers of Olig2 +ve cells seen within the neocortex. This finding implies that the burst of glial progenitor cells produced by the activation of precocious proliferation within the SVZ (in reaction to GMH/IVH) is unable to integrate within the cortex and that the developing cortex is unable to compensate for the loss of potential and abnormal temporal activation.
These intriguing findings led us to speculate that GMH may have been impacting the molecular control of NSPC within the proximal/ventricular domain of the SVZ in our model. To address this question, we decided to isolate cells from the proximal/ventricular domain of the neonatal pup using a CD133 MACS protocol. Whilst no single marker has been demonstrated to show absolute sensitivity and specificity, CD133 is a robust and widely accepted marker of ependymal cells and NSC in the early postnatal brain [30] .
Expression analysis demonstrated that moderategrade GMH downregulates Notch2 within the CD133 +ve cell fraction ( Fig. 6 a) . The periventricular location of Notch signalling downregulation following GMH was confirmed using in situ hybridisation directed against Hes5, a downstream effector of the Notch pathway ( Fig. 6 c) .
The role of the Notch signalling pathway in the maintenance and differentiation of SVZ NSC is well characterised. Evidence of activation of the pathway in quiescent NSC was shown in transgenic mice in which the expression of a reporter gene was driven by the Hes5 promoter or RBPj-binding sites, and its main role was found to be the maintenance of the pool of undifferentiated quiescent NSC [14] . In fact, conditional inactivation of the pathway led to a premature conversion of slowly dividing NSC into transient amplifying cells, a phenomenon accompanied by a proliferative burst which led to premature differentiation of the cells and to depletion of the pool of undifferentiated NSC as well as subsequent premature cessation of neurogenesis [14] . In our model of GMH, we found profound disruption of the SVZ including the ependymal lining and concomitant decrease in Notch activity as assessed based on a reduced number of cells expressing the Notch signalling downstream effector Hes5. It is conceivable that the decreased Notch signalling may be responsible for the proliferative burst of transient amplifying progenitors observed at P4. These data are in agreement with previous studies in which disruption of the ependymal cells by an ischaemic injury led to decreased Notch signalling, which in turn induced a fate change followed by cell cycle entry and neuronal differentiation [60] . We did not observe increased neuronal differentiation in our model at P21 but we did see decreased oligodendrogenesis instead, possibly because our injury strategy mainly affects the dorsal and anterior SVZ, an area where NSC with oligodendrocytic potential are enriched for [61] . These results are also in keeping with the reported role of Notch signalling in favouring oligodendrocytic specification [62] .
Furthermore, Notch has an important role in dendritic arborisation of immature neurons in the adult brain. In fact, conditional knockout of Notch 1 results in significantly less complex arborisation, while overexpression of activated Notch 1 leads to a significant increase in dendritic complexity in newborn, maturing granule cells of the adult dentate gyrus [63] . Future studies will tell whether similar abnormalities are seen at later stages in our mouse model, since they could provide a preliminary explanation for subtler neurocognitive sequelae suffered by GMH patients later in their life.
It will be important to assess the translational value of these findings in human autoptic GMH brain tissue as Notch downregulation may represent a final common pathway following premature birth. Should this be the case, quantification of Notch expression in the GM may prove a useful prognostic indicator and, importantly, pharmacological activation of the Notch pathway, which has been shown to be achievable and to exert the predicted functional impact in human cells [64, 65] , could be therapeutically pursued.
Taken together, these findings raise the possibility that activation of Notch signalling could be a therapeutic strategy for GMH and our mouse model would be an ideal platform to test this hypothesis at a preclinical level.
